Patent ID: 7576106

Claim:
A compound having formula I and pharmaceutically acceptable salts and N-oxides thereof; wherein R 2a , R 2b , R 2c , R 2d and R 2e are each independently selected from the group consisting of hydrogen, halogen, —OR c , —R e and CN, wherein each R c is independently selected from hydrogen, C 1-8 alkyl, and C 1-8 haloalkyl; and each R e is independently selected from the group consisting of C 1-8 alkyl and C 1-8 haloalkyl, and at least one of R 2a , R 2b , R 2c , R 2d and R 2e is other than hydrogen; B is pyrazolyl and is substituted with 0 to 3 R 3 substituents, and at each occurrence, R 3 is independently selected from the group consisting of halogen, —R h , —CN and —Y, wherein Y is a member selected from the group consisting of oxazolyl, pyridyl, pyrimidinyl, oxadiazolyl and thiazolyl and each R h is independently selected from the group consisting of C 1-8 alkyl and C 1-8 haloalkyl; L 1 is a linking group selected from the group consisting of C 1-4 alkylene and C 2-4 alkenylene; and A is a member selected from the group consisting of hydrogen and —OR q , wherein R q is selected from the group consisting of hydrogen, C 1-8 alkyl and C 1-8 haloalkyl.